Cargando…

Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort

Background: Cardiovascular disease (CVD) screening entails precise event prediction to orient risk stratification, resource allocation, and insurance policy. We used random survival forests (RSF) to identify markers of incident CVD among Japanese adults enrolled in an employer-mandated screening pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Matheson, Matthew B., Kato, Yoko, Baba, Shinichi, Cox, Christopher, Lima, João A.C., Ambale-Venkatesh, Bharath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726526/
https://www.ncbi.nlm.nih.gov/pubmed/36530840
http://dx.doi.org/10.1253/circrep.CR-22-0101
_version_ 1784844807486570496
author Matheson, Matthew B.
Kato, Yoko
Baba, Shinichi
Cox, Christopher
Lima, João A.C.
Ambale-Venkatesh, Bharath
author_facet Matheson, Matthew B.
Kato, Yoko
Baba, Shinichi
Cox, Christopher
Lima, João A.C.
Ambale-Venkatesh, Bharath
author_sort Matheson, Matthew B.
collection PubMed
description Background: Cardiovascular disease (CVD) screening entails precise event prediction to orient risk stratification, resource allocation, and insurance policy. We used random survival forests (RSF) to identify markers of incident CVD among Japanese adults enrolled in an employer-mandated screening program. Methods and Results: We examined biomarker, health history, medication use, and lifestyle data from 155,108 adults aged ≥40 years. The occurrence of coronary artery disease (CAD) or atherosclerotic CVD (ASCVD) events was examined over 6 years of follow-up. The analysis used RSF to identify predictors, then investigated simplified RSF models with fewer predictors for individual-level risk prediction. Data were split into training (70%) and test (30%) datasets. At baseline, the median patient age was 47 years (interquartile range 41–56 years), with 65% males. In all, 1,642 CAD and 2,164 ASCVD events were observed. RSF identified history of heart disease, age, self-reported blood pressure medication, HbA1c, fasting blood sugar, and high-density lipoprotein as important markers of both endpoints. RSF analyses with only the top 20 predictors demonstrated good performance, with areas under the curve of >84% for CAD and >82% for ASCVD in test data across 6 years. Conclusions: We present a machine learning technique for accurate assessment of cardiovascular risk using employer-mandated annual health checkup information. The algorithm produces individual-level risk curves over time, empowering clinicians to efficiently implement prevention strategies in a low-risk population.
format Online
Article
Text
id pubmed-9726526
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Circulation Society
record_format MEDLINE/PubMed
spelling pubmed-97265262022-12-16 Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort Matheson, Matthew B. Kato, Yoko Baba, Shinichi Cox, Christopher Lima, João A.C. Ambale-Venkatesh, Bharath Circ Rep Original article Background: Cardiovascular disease (CVD) screening entails precise event prediction to orient risk stratification, resource allocation, and insurance policy. We used random survival forests (RSF) to identify markers of incident CVD among Japanese adults enrolled in an employer-mandated screening program. Methods and Results: We examined biomarker, health history, medication use, and lifestyle data from 155,108 adults aged ≥40 years. The occurrence of coronary artery disease (CAD) or atherosclerotic CVD (ASCVD) events was examined over 6 years of follow-up. The analysis used RSF to identify predictors, then investigated simplified RSF models with fewer predictors for individual-level risk prediction. Data were split into training (70%) and test (30%) datasets. At baseline, the median patient age was 47 years (interquartile range 41–56 years), with 65% males. In all, 1,642 CAD and 2,164 ASCVD events were observed. RSF identified history of heart disease, age, self-reported blood pressure medication, HbA1c, fasting blood sugar, and high-density lipoprotein as important markers of both endpoints. RSF analyses with only the top 20 predictors demonstrated good performance, with areas under the curve of >84% for CAD and >82% for ASCVD in test data across 6 years. Conclusions: We present a machine learning technique for accurate assessment of cardiovascular risk using employer-mandated annual health checkup information. The algorithm produces individual-level risk curves over time, empowering clinicians to efficiently implement prevention strategies in a low-risk population. The Japanese Circulation Society 2022-11-11 /pmc/articles/PMC9726526/ /pubmed/36530840 http://dx.doi.org/10.1253/circrep.CR-22-0101 Text en Copyright © 2022, THE JAPANESE CIRCULATION SOCIETY https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
spellingShingle Original article
Matheson, Matthew B.
Kato, Yoko
Baba, Shinichi
Cox, Christopher
Lima, João A.C.
Ambale-Venkatesh, Bharath
Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title_full Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title_fullStr Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title_full_unstemmed Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title_short Cardiovascular Risk Prediction Using Machine Learning in a Large Japanese Cohort
title_sort cardiovascular risk prediction using machine learning in a large japanese cohort
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726526/
https://www.ncbi.nlm.nih.gov/pubmed/36530840
http://dx.doi.org/10.1253/circrep.CR-22-0101
work_keys_str_mv AT mathesonmatthewb cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort
AT katoyoko cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort
AT babashinichi cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort
AT coxchristopher cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort
AT limajoaoac cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort
AT ambalevenkateshbharath cardiovascularriskpredictionusingmachinelearninginalargejapanesecohort